摘要
目的研究瘢痕子宫再次妊娠经阴道试产的妊娠结局和安全性。方法选取2018年1月至12月滨海县人民医院接收的36例瘢痕子宫再次妊娠患者(依据患者最终分娩结果分成选择阴道分娩组与选择剖宫产组)与足月经阴道分娩的初产妇36例(对照组)。观察3组患者的妊娠结局、新生儿Apgar评分、住院时间、住院费用、24 h出血量及并发症发生率。结果3组患者的新生儿Apgar评分比较,差异无统计学意义(P>0.05)。对照组及选择阴道分娩组患者的住院时间、住院费用、并发症发生率及24 h出血量均少于选择剖宫产组,差异均有统计学意义(P<0.05)。结论对符合阴道试产条件的瘢痕子宫再次妊娠患者采用阴道试产能有效改善不良妊娠,减少产后出血量,加快产妇的恢复时间,安全性好。
Objective To study the pregnancy outcome and safety of trial vaginal delivery of scarred uterus repregnancy.Methods From January to December 2018,36 cases of re-pregnancy with scarred uterus(according to the final delivery results,the patients were divided into the vaginal delivery group and cesarean section group)and 36 cases of primipara with full-term vaginal delivery(control group)were selected in Binhai People's Hospital.The pregnancy outcome,Apgar score of newborn,length of stay,hospitalization expenses,24 h bleeding volume and complication rate were compared between the three groups.Results There was no significant difference in Apgar score among the three groups(P>0.05).The hospitalization time,expenses complication incidence rate and 24 h bleeding volume of the control group and the vaginal delivery group were all significantly less than those of the cesarean section group(P<0.05).Conclusion Vaginal trial delivery can effectively improve the adverse pregnancy,reduce postpartum blood loss,and accelerate the recovery time of parturient with scarred uterus meeting the requirements of vaginal trial delivery,with a high safety.
作者
于秋兰
袁萍
陈娟奇
YU Qiulan;YUAN Ping;CHEN Juanqi(Binhai People's Hospital,Yancheng,Jiangsu 224500China)
出处
《大医生》
2019年第15期168-169,共2页
Doctor
关键词
瘢痕子宫
再次妊娠
临床效果
安全性
妊娠结局
scarred uterus
repregnancy
clinical effect
safety
pregnancy outcome
